Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA as a sponsor: 5 trials, 5 as lead sponsor and 0 as collaborator.
Phase and status
| Phase | Completed | Terminated | All statuses |
|---|---|---|---|
| Phase 2 | 2 | 0 | 2 |
| Phase 3 | 2 | 1 | 3 |
| All phases | 4 | 1 | 5 |
Start year
| Start year | Trials |
|---|---|
| 2022 | 1 |
| 2021 | 3 |
| 2018 | 1 |
Main conditions
Main countries
- France
- Germany
- Israel
- Spain
- United Kingdom
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Sponsor class
- INDUSTRY
Record details
- Record id
cardio:org-acceleron-pharma-inc-a-wholly-owned-subsidiary-of-merck-co-341e98- Content hash
fe4673c0e94ae6cd53cab67aefc77d6c9303a3837b9e8cf63422d681a5ad3ceb